| Details | Specifications |
|---|---|
Therapeutic Category |
Antineoplastic agent (cancer treatment drug) and a type of hormone therapy used for the treatment of prostate cancer. |
CAT No. |
E430000 |
CAS No. |
915087-33-1 |
Mol. Weight |
464.44 g/mol. |
Dosage Form |
oral capsule and an oral tablet |
Appearance |
white to off-white crystalline |
Synonyms |
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide |
Storage |
In a tightly closed container at Control room temperature, away from excess heat, moisture, and direct light |
Disclaimer:
The contents on this website is provided solely for informational purposes and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you have any questions about a medical problem, please consult a physician or other authorized health expert. Do not dismiss or postpone getting competent medical advice because of something you read on this website.
Happy Customers
Projects Successfully Completed
Established
PhD Experts Driving R&D Excellence
Team Size
World-Class API Manufacturing Sites
Global Audits Successfully Completed
Comprehensive CDMO Service Offerings
Everything You Need to Know About Shilpa Pharma
